Updated:
AVANIR PHARMACEUTICALS, INC.
AVANIR PHARMACEUTICALS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000858803, and its reported...
Overview
AVANIR PHARMACEUTICALS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000858803, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2014-12-10, it reported annual revenue of USD 115,029,000; net income of USD -50,436,000; total assets of USD 306,983,000 for the fiscal period ended 2014-09-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- AVANIR PHARMACEUTICALS, INC.
- Former names in filing history
- AVANIR PHARMACEUTICALS (1998-12-07 to 2009-04-02); LIDAK PHARMACEUTICALS (1995-11-21 to 1998-08-14)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Aliso Viejo, CA, United States
- Incorporated in
- DE
- Fiscal year end
- September 30
- SEC CIK
- 0000858803
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2014USD | $115.0M | -$50.4M | $307.0M | $271.9M | — | |
| FY2013USD | $75.4M | -$75.5M | $76.1M | $55.3M | -$65.4M | |
| FY2012USD | — | -$59.7M | $86.0M | $69.8M | -$57.7M | |
| FY2011USD | — | -$60.6M | $89.6M | $79.5M | -$56.5M |
FY2013. Revenue, Net income, Total assets, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
FY2012. Net income, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
FY2011. Cash and equivalents: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| SC 13G | — | SC 13G | |
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research AVANIR PHARMACEUTICALS, INC. in Altss
Track this company’s investors, transactions and relationships in Altss.